Lowell biotech brings in $23M for CNS gene therapy

After about a decade in operation, Alcyone Therapeutics is finally emerging from stealth with $23 million as it prepares its gene therapy programs for the clinic.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news